A modern view of phenylalanine ammonia lyase
Tóm tắt
Phenylalanine ammonia lyase (PAL; E.C.4.3.1.5), which catalyses the biotransformation of l-phenylalanine to trans-cinnamic acid and ammonia, was first described in 1961 by Koukol and Conn. Since its discovery, much knowledge has been gathered with reference to the enzyme’s catabolic role in microorganisms and its importance in the phenyl propanoid pathway of plants. The 3-dimensional structure of the enzyme has been characterized using X-ray crystallography. This has led to a greater understanding of the mechanism of PAL-catalyzed reactions, including the discovery of a recently described cofactor, 3,5-dihydro-5-methyldiene-4H-imidazol-4-one. In the past 3 decades, PAL has gained considerable significance in several clinical, industrial, and biotechnological applications. The reversal of the normal physiological reaction can be effectively employed in the production of optically pure l-phenylalanine, which is a precursor of the noncalorific sweetener aspartame (l-phenylalanyl-l-aspartyl methyl ester). The enzyme’s natural ability to break down l-phenylalanine makes PAL a reliable treatment for the genetic condition phenylketonuria. In this mini-review, we discuss prominent details relating to the physiological role of PAL, the mechanism of catalysis, methods of determination and purification, enzyme kinetics, and enzyme activity in nonaqueous media. Two topics of current study on PAL, molecular biology and crystal structure, are also discussed.
Từ khóa
Tài liệu tham khảo
Adachi O., 1990, Agric. Biol. Chem., 54, 2839
Battistel, E., and Bianchi, D. 1994. Thermostability of ribonuclease in organic solvents: a calorimetric and spectroscopic study. J. Phys. Chem.98: 5368–5375.
Deshpande A.S., 1993, Indian J. Biochem. Biophys., 30, 36
Donlon, J., Levy, H., and Scriver, C.R. 2004. Hyperphenylalaninemia: phenylalanine hydroxylase deficiency.InThe metabolic and molecular bases of inherited disease.Edited byScriver, C.R., Beaudet, A.R., Sly, W., and Valle, D. McGraw Hill, New York. pp. 1821–1838.
Hamilton, B.K., Hsiao, H.Y., Swann, W., Anderson, D., and Delente, J. 1985. Manufacture ofl-amino acids with bioreactors. Trends Biotechnol.3: 64–68.
Hsia, D.Y. and Holtzmann, N.A. 1973. A critical evaluation of phenylketonuria screening.InMedical genetics.Edited byMcKusick, V.A. and Claiborne, R. HP Publishing, N.Y. pp. 237–244.
Khan N.U., 1989, Curr. Sci., 58, 427
Kilbanov, A.M. and Ahern, T.J. 1987. Thermostability of proteins.InProtein engineering.Edited byOxender, D.L. and Fox, C.F. Alan R. Liss, N.Y. pp. 213–218.
Mozhaev, V.V., Poltevsky, K.G., Slepnev, V.I., Badun, G.A., and Levashov, A.V. 1991. Homogenous solutions of hydrophilic enzymes in nonpolar organic solvents: new systems for fundamental studies and biocatalytic transformations. FEBS Lett.292: 159–161.
Ogata K., 1967, Agric. Biol. Chem., 31, 200
Scriver, C.R., and Kaufman, S. 2001. Hyperphenylalaninemia: phenylalanine hydroxylase deficiency.InThe metabolic and molecular bases of inherited disease. McGraw Hill, New York.
Wall M.J., 2006, Proc. N. S. Inst. Sci., 43, 219
Watanabe S.K., 1992, Biotechnol., 8, 406
Zaks, A. and Klibanov, A.M. 1984. Enzymatic catalysis in organic media at 100 degrees C. Science, (Washington, D.C.),224: 1249–1251.